The first Reata Pharmaceuticals trade was made in Q3 2017.
Since then Ken Griffin bought shares 37 more times and sold shares on 26 occasions. The investor completely sold their stake between Q2 2023 and Q3 2023.
Avg closing price
Price range
Sold -572 Thousand shares
Q3 2023
Avg closing price
$150.64
Price range
$102.88
-
$172.36
Increased shares by 1674.5% (+539 Thousand shares)
Q2 2023
Avg closing price
$94.63
Price range
$79.22
-
$105.37
Sold 56.8% shares (-42.4 Thousand shares)
Q1 2023
Avg closing price
$58.68
Price range
$30.85
-
$93.17
Sold 53.9% shares (-87.2 Thousand shares)
Q4 2022
Avg closing price
$34.41
Price range
$22.15
-
$42.11
Sold 29.2% shares (-66.7 Thousand shares)
Q3 2022
Avg closing price
$27.71
Price range
$19.32
-
$36.49
Increased shares by 77.3% (+99.7 Thousand shares)
Q2 2022
Avg closing price
$29.83
Price range
$20.71
-
$36.50
Increased shares by 113.2% (+68.4 Thousand shares)
Q1 2022
Avg closing price
$29.67
Price range
$24.12
-
$39.60
Increased shares by 875.6% (+54.2 Thousand shares)
Q4 2021
Avg closing price
$77.38
Price range
$25.61
-
$110.96
New holding (+6.19 Thousand shares)
Q3 2021
Avg closing price
$117.22
Price range
$100.00
-
$143.02
Sold -21.2 Thousand shares
Q2 2021
Avg closing price
$112.92
Price range
$78.27
-
$151.29
Sold 37.3% shares (-12.6 Thousand shares)
Q1 2021
Avg closing price
$116.64
Price range
$94.25
-
$132.81
Sold 37.0% shares (-19.9 Thousand shares)
Q3 2020
Avg closing price
$124.95
Price range
$93.53
-
$163.34
Sold 29.2% shares (-22.1 Thousand shares)
Q2 2020
Avg closing price
$152.02
Price range
$126.30
-
$176.56
Increased shares by 123.5% (+42 Thousand shares)
Q1 2020
Avg closing price
$193.06
Price range
$124.16
-
$247.74
Increased shares by 154.0% (+20.6 Thousand shares)
Q4 2019
Avg closing price
$182.82
Price range
$74.57
-
$217.92
Increased shares by 69.9% (+5.5 Thousand shares)
Q3 2019
Avg closing price
$84.86
Price range
$71.26
-
$95.75
Sold 46.5% shares (-6.83 Thousand shares)
Q2 2019
Avg closing price
$86.34
Price range
$77.72
-
$94.35
Increased shares by 170.7% (+9.27 Thousand shares)
Q1 2019
Avg closing price
$83.01
Price range
$51.90
-
$101.79
Sold 86.5% shares (-34.7 Thousand shares)
Q4 2018
Avg closing price
$61.05
Price range
$48.76
-
$76.44
Increased shares by 384.9% (+31.9 Thousand shares)
Q3 2018